1989 Volume 53 Issue 11 Pages 3025-3030
The biological activities of eckol, a novel phlorotannin with a dibenzo-p-dioxine skeleton, were examined. Eckol inhibited the antiplasmin activity of α2-plasmin inhibitor very efficiently (IC50; 1.6μg/ml) as well as those of α2-macroglobulin and α1-antitrypsin. However, its inhibitory effect on the antithrombin III-heparin complex was very weak. Eckol also showed inhibitory activity on thrombin (IC50; 12μg/ml), but not on plasmin. Its inhibitory activity was reduced in whole human plasma, but at concentrations of above 200μg/ml it enhanced urokinase-induced fibrinoly sis in human plasma. Studies on the inhibitory spectra of several derivatives of eckol showed that the dibenzo-1, 4-dioxane skeleton was necessary for inhibition of plasmin inhibitor. These observations suggest that eckol or its derivatives may be useful clinically for potentiating thrombolytic activity.
This article cannot obtain the latest cited-by information.